Skip to main content

Table 2 Comparison of the mRNA expression of MMP9 among the treatment groups x ¯ ± SD

From: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer

Group n MMP9 mRNA  
DMSO 10 1.320 ± 0.0524  
CoCl2 10 0.881 ± 0.0723  
glibenclamide 10 0.941 ± 0.0948 F = 447.86 P = 0.021
CoCl2 + glibenclamide 10 0.481 ± 0.0685  
paclitaxel 10 0.424 ± 0.0517